Radiotoxicity of h-R3 monoclonal antibody labeled with 188Re administered intracerebrally in rats

Human and Experimental Toxicology

Volumn 19, Issue 12, 2000, Pages 684-692

  Gonzalez, B ^a   Casaco, A ^b   Alvarez, P ^c   Leon, M ^d   Arteaga, M ^a   Leon, A ^a   Santana, E ^a   Bada, A ^a   Figueredo, R ^b   Hernandez, R ^d   Iznaga Escobar, N ^b   Gonzailez, F ^a   Perez, R ^b  

^a Centro Nacional para la Producción de Animales de Laboratorio CENPALAB   (Cuba)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^c CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^d Centro de Isotopos Cuba   (Cuba)

Author keywords

Cancer treatment; H R3; Monoclonal antibody; Radiotoxicity; Rheunium

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; RECOMBINANT EPIDERMAL GROWTH FACTOR; RHENIUM 188;

ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; HISTOPATHOLOGY; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION NECROSIS; RAT;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; BODY WEIGHT; BRAIN; CLINICAL CHEMISTRY TESTS; FEMALE; HEMATOLOGIC TESTS; HUMANS; INJECTIONS, INTRAVENTRICULAR; LUNG NEOPLASMS; MALE; NECROSIS; ORGAN SIZE; RADIATION INJURIES, EXPERIMENTAL; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RHENIUM; STEREOTAXIC TECHNIQUES; TOXICITY TESTS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 17744365187     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032700675323269     Document Type: Article

References (31)

1. The new approaches to brain tumors cancer
2. The prognostic value of epidermal growth factor receptor in primary breast cancer: Results of a 10 year follow-up study
3. Amplification and enhanced expression of the EGF-R gene in A431 human carcinoma cells
4. Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver
5. The epidermal growth factor receptor as a target for therapy in breast carcinoma
6. Epidermal growth factor receptors in human breast cancer
7. Epidermal growth factor receptors in non-small cell lung cancer
8. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
9. Signal transduction pathways and their relevance in human astrocytomas
10. Expiation of an altered epidermal growth factor receptor by human glioblastoma cells
11. Indium 111 labeled anti EGF-R 425 scintigraphy and the detection of malignant gliomas
12. Generación y caracterización primaria de anticuerpos monoclonales contra el receptor del factor de crecimiento epidérmico
13. A new monoclonal antibody for detection of EGF-receptors in Western blots and paraffin-embedded tissue sections
14. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: Recovery of antagonistic activity
15. 99mTc-labeled anti-EGF-receptor antibody (ior egf/r3) in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy
16. Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas
17. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy
18. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: Results of Phase I trials
19. Radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphomas using iodine-131 labeled monoclonal antibody
20. Micromethod for quantification of SH groups generated after reduction of monoclonal antibodies
21. 99mTc-human serum albumin
22. Sedative and hypnotics I: Nonbarbiturates
23. Effect of general microdialysis-induced depletion on extracellular dopamine
24. Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesion of substantia nigra
25. Supratentorial malignant glioma: Patterns of recurrence and implications for externalbean local treatment
26. Assumption in the radiotherapy of glioblastoma
27. 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies
28. 2 fragment delivery to tumor in patients with glioma: Comparison of intracarotid and intravenous administration
29. Monoclonal antibodies in the treatment of central nervous system malignancies
30. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: Significance of elevated interstitial pressure